Feasibility and safety profile of high-dose oxaliplatin-based PIPAC (120mg/m2) in the treatment of advanced peritoneal metastatic disease: MINOS real-life multicenter study. - Zambrano DA; Lintis A; Kefleyesus A; Taibi A; Eveno C; Pocard M; De Meeus G; Quénet F; Kepenekian V; Hübner M; Glehen O; Sgarbura O (European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2026)